SCOTTSDALE, Ariz., April 23,
2024 /PRNewswire/ -- Amendola, a nationally
recognized, award-winning healthcare technology and life sciences
public relations and marketing firm, today announced that it
has been selected to implement a national PR program by Peerbridge
Health, developer of a hospital-grade, remote diagnostic and
monitoring platform that harnesses artificial intelligence (AI) for
early detection of heart failure and other conditions.
"Amendola comes highly recommended by healthcare technology
peers, giving us confidence that its industry-specific expertise
and successful track record will produce valuable results," said
Chris Darland, CEO of Peerbridge
Health. "We look forward to working with Amendola to educate the
industry on the life-saving potential of early detection of heart
failure through AI-enabled remote monitoring technology, which we
are able to offer at a significantly lower cost compared to
traditional methods."
More than 6 million Americans live with heart failure, and each
year around 1 million new cases are diagnosed in adults 55 years of
age and over. Heart failure is the second-leading cause of
hospitalization in the U.S. and the leading cause of
hospitalization among adults 65 and older.
To reduce the impact of heart failure, Peerbridge Health has
developed the Peerbridge Cor™, an AI-enabled, 3-lead, 2-channel
wireless ambulatory ECG device. A recent feasibility trial showed
the device had a nearly 96% accuracy rate in identifying heart
failure in patients utilizing ECG as the only input.
"Heart failure is a serious condition that is often only
diagnosed after a visit to the emergency room," said agency CEO
Jodi Amendola. "We are pleased to
partner with Peerbridge Health in its efforts to extend access to
care, improve outcomes for cardiac patients, and reduce the
financial burden of this disease."
About Amendola
Amendola is an award-winning,
insights-driven public relations and marketing firm that integrates
media relations, social media, content and lead gen programs to
move healthcare, life sciences/pharma and healthcare IT
decision-makers to action. The agency represents some of the
industry's best-known brands as well as groundbreaking startups
that are disrupting the status quo. Nearly 90% of its client base
represents multi-year clients and/or repeat client executives.
Amendola's seasoned team of PR and marketing pros understand the
ongoing complexities of the healthcare ecosystem and provide
strategic guidance and creative direction to drive positive ROI,
boost reputation and increase market share. Making an impact since
2003, Amendola combines traditional and digital media to fuel
meaningful and measurable growth. For more information about the
industry's "A-Team," visit www.acmarketingpr.com, and follow us on
Twitter and LinkedIn.
About Peerbridge Health
Peerbridge Health is
revolutionizing cardiac care as the first company to bring the
quality and accuracy of hospital-grade cardiac diagnostics to the
home. The company's AI-enabled device, Peerbridge Cor™, includes a
three-lead, patented AECG wearable device that features a design
based on the Einthoven Triangle. The Peerbridge platform leverages
ECG to diagnose and monitor the most important elements of cardiac
care at a lower cost than ever before. Data captured provides
actionable insights that promote early invention, reduce hospital
visits and saves lives. For more, go to peerbridgehealth.com or
visit our LinkedIn page.
Media Contact:
Marcia G.
Rhodes, mrhodes@acmarketingpr.com, Amendola
Communications
View original content to download
multimedia:https://www.prnewswire.com/news-releases/peerbridge-health-chooses-amendola-for-public-relations-program-to-educate-market-on-remote-heart-failure-detection-302123878.html
SOURCE Amendola Communications